ASP3662

DRUG2 trials

Sponsors

Astellas Pharma Global Development, Inc.

Conditions

Displacement of RadiotracerHealthy VolunteersPainful Diabetic Peripheral Neuropathy (PDPN)Pharmacokinetics of ASP3662

Phase 1

A Positron Emission Tomography Occupancy Study Using Ligand [11C]AS2471907 and Following Oral Dosing of ASP3662

CompletedNCT02194491

Astellas Pharma Global Development, Inc.Displacement of Radiotracer, Healthy Volunteers, Pharmacokinetics of ASP3662

Start: 2014-04-30End: 2016-05-31Updated: 2016-06-28

Phase 2

Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy

TerminatedNCT02372578

Astellas Pharma Global Development, Inc.Painful Diabetic Peripheral Neuropathy (PDPN)

Start: 2015-05-27End: 2016-05-20Updated: 2019-03-26

Related Papers

1807-P: Cardiometabolic Effects of Clofutriben (CLO) in Adults with Type 2 Diabetes (T2D): A Six-Week, Phase 2, Placebo-Controlled, Randomized Clinical Trial

Diabetes2026-06-05